Max Robotics — Global Service Robot Directory + US Certification

About

Kirsti Aas is a clinical researcher focused on advancing the surgical and diagnostic management of prostate cancer, with key contributions in MRI-based risk stratification and the functional outcomes of robot-assisted surgery. Her most cited work, an external validation study of nomograms incorporating MRI features for predicting side-specific extraprostatic extension (2023, 10 citations), directly addresses the critical challenge of accurately staging prostate cancer preoperatively—helping surgeons tailor nerve-sparing approaches and reduce overtreatment. Aas also investigates patient-reported outcomes, as demonstrated in her 2024 study on the reduction of lower urinary tract symptoms following robot-assisted laparoscopic prostatectomy (RALP), which analyzed nearly 2,000 patients to identify predictors of symptom improvement. Her ongoing impact is highlighted by the prePSMA clinical trial protocol (2025), a multicenter, randomized noninferiority trial evaluating whether preoperative PSMA PET/CT can triage the need for extended pelvic lymph node dissection in RALP candidates—a study with the potential to change surgical standards. Through these works, Aas bridges imaging innovation and surgical precision, earning citations that underscore her role in refining prostate cancer care from diagnosis through recovery.